POET Technologies Moves to Next Phase of Commercialization

New Post Public Reply Private Reply Replies (1) Message Board
sevenOdouble Flex #7489
POET Technologies Moves to Next Phase of Commercialization Plan, Endorses Recommendations of Special Strategic Committee

TORONTO, ONTARIO and STORRS, CONNECTICUT--(Marketwired - Aug. 16, 2013) - POET Technologies Inc. (TSX VENTURETK)(OTCQXOETF) ("the Company") - developer of the proprietary planar-optoelectronic technology ("POET") platform for monolithic fabrication of integrated electronic and optical devices on a single semiconductor wafer - announced today that its Board of Directors have endorsed the next phases of the Company's commercialization plan put forward by the Special Strategic Committee (SSC) chaired by Executive Director Peter Copetti.

The multi-pronged approach is based on discussions with potential industry partners and advisers regarding the Company's two key markets consisting of the military and commercial sector that have been identified as potential early adopters of the POET platform. Currently, while POET's incorporation in military projects is proceeding well, and should provide value in several key verticals, significant value exists in adapting POET for mass production within a commercial semiconductor fab environment. The Company must rapidly move to the next phase of its commercialization plan, which includes addressing feature size and scalability requirements for commercial fabs.

The Board has therefore endorsed, and authorized the SSC to proceed on, these recommendations, including:

Establishing a POET Development Alliance (PDA) - The Company will be establishing relationships with one or more industrial partners looking towards jointly adapting POET to commercial scale III-V implementation. Alliance partners will provide key input including intellectual assets, technical staff, manufacturing capability, and foundry resources. In addition to optimizing device parameters and yields, a near-term goal will be to establish comprehensive design rules and a device parameter library for POET, which will proliferate licensed designs in a POET device ecosystem.

Drive for Reduction of Feature Size to 100-nm Range (100NM) - The Company will re-prioritize its technical roadmap by introducing specific milestones associated with reducing feature size from the sub-micron to the 100-nm range in scale, targeting 4Q2013 for that milestone. Consequently, the milestone for full optoelectronic integration on a single die will be re-scheduled to 2Q2014. Even without this full integration milestone, the 100-nm goal anticipates the cadence of commercial III-V foundry capabilities. This roadmap will focus the Company's ODIS subsidiary on developmental work that will allow for scalable production within existing commercial fabs.

Adoption of a Shareholder Rights Plan (SRP) - The Company will be structuring a special SRP to protect the potential value of the company, for all shareholders, during the period where discussions with potential partners may be taking place regarding PDA-related agreements, and as progress on the 100NM project continues.
"This move crystallizes the Company's strategy for unlocking the value of our intellectual property," said Mr. Copetti. "A development alliance with the right partners will definitely shorten time-to-market, and help evolve a design ecosystem for POET in the marketplace."

Further SSC actions will be endorsed by the Board depending on the status of the above initiatives.

Mr. Copetti added, "While the new feature-size milestone is a challenge given our commitment to projects in our delivery pipeline, I believe the POET team is more than capable of achieving this goal. There is no doubt that POET can demonstrate its n- and p-channel capability to be a viable and scalable complement to silicon CMOS."

The Company's proprietary POET platform has demonstrated monolithic fabrication of integrated circuit gallium arsenide (GaAs) based devices containing both electronic and optical elements on a single wafer.

By offering components with the potential for increased speed, density, reliability, and lower costs, POET offers the semiconductor industry the ability to push Moore's Law to the next cadence level, overcoming current silicon-based bottlenecks, and potentially changing the roadmap for a broad range of applications.

The POET platform is currently the basis for a number of key projects - including optical code division multiple access (OCDMA) devices for avionics systems, combined RF/optical phased arrays, optoelectronic directional couplers, and ultra-low-power random access memory (RAM).
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Palmdale Propane Expands with Affordable Gas Buy

Updated Category News Views 0

Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...

Continue Reading
Flex LNG Readies for Crucial Q3 Earnings Reveal

Updated Category News Views 64

Anticipation Builds for Flex LNG's Upcoming Q3 Reveal The air's thick with expectation as Flex LNG gears up to lay its cards on the table for the third quarter of 2026. Come November 11, the company will spill the beans on its financial dance over the last few months, promising to unfurl the numbers early in the morning like a farmer checking crops at dawn—07:00 CET...

Continue Reading
OppFi's Q3 2026: Is Their Growth Strategy on Track?

Updated Category News Views 46

OppFi's Third Quarter Performance Unpacked OppFi's recent third-quarter disclosures should get investors pondering. They've launched a new line of credit product, plugging a gap in their service portfolio, and aimed to widen their customer net. Their targeted share repurchase of $6.7 million in stock isn't small potatoes either, showing a vote of confidence in their own...

Continue Reading
TENX Faces Class Action Over Misleading Investors

Updated Category News Views 52

How Tenax Landed in Hot Water Right off the bat, Tenax's world seems to revolve around a miracle drug called levosimendan. Now, the kicker here is what they promised and what reality threw back. We're talking about a pharmaceutical company whose tall tales supposedly cloaked the true nature of TNX-103's effectiveness—or the lack thereof. A whole class action lawsuit's...

Continue Reading
FirstLight Home Care Reaches 300 Locations Milestone

Updated Category News Views 32

FirstLight Celebrates a Major Milestone FirstLight Home Care just hit a big milestone, reaching a whopping 300 locations. That's not just a feather in their cap; it's a sign that their approach to senior care is resonating with communities across the map. The company is kicking off a celebration tour, cleverly dubbed the Best Days Tour, highlighting each step forward with...

Continue Reading
White House Photographer Reveals Unseen Historic Moments

Updated Category News Views 16

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Continue Reading
ReachWell Revamps Platform for Better Community Reach

Updated Category News Views 49

ReachWell's Fresh Approach: A New Era Begins Become the whisper in the wind reaching ears far and wide—enter the new ReachWell. Sounds lofty? Well, it's shooting for the stars here, folks. This isn’t just some tech upgrade. It’s a whole new brand identity and a refreshed sense of purpose. These guys have tossed everything back on the drawing board, unveiling a...

Continue Reading
Infrastructure Capital's ETFs: Dividend Windfall

Updated Category News Views 98

Payout Boost for Income-Hungry Investors You know, it ain't every day you hear about dividend increases across the board. But Infrastructure Capital Advisors, that investment management powerhouse, is dishing out more dough to its investors through a dividend uptick. They're bumping up the payouts on not just one, but four of their ETFs: Bond Income ETF (BNDS), Equity...

Continue Reading
Wendy's Faces Takeover Bid Amid Strategic Focus Shift

Updated Category News Views 58

Behind the Unsolicited Offer Folks, it looks like Wendy's (NASDAQ:WEN) got itself mixed up in some high-stakes shenanigans. An unsolicited, non-binding proposal slammed into them, courtesy of the Investor Group led by Trian Partners, Flynn Group LP, BlueFive Capital, and Sixth Street Partners, itching to scoop up every last piece of Wendy’s stock they ain't already...

Continue Reading
LabWare Loop: A Game Changer for Lab Data Integrity

Updated Category News Views 76

Breaking Down Silos in Lab Environments When it comes to the controlled chaos of laboratory operations, data integrity is the name of the game. We're talking about a new way of doing things that doesn't demand a physics degree just to connect the dots between gizmos and databases. Enter LabWare Loop, a solution that's rewriting the data playbook by linking multi-vendor...

Continue Reading

Top 5 Most Recently Viewed Articles

Fractyl Health and Bariendo Team Up for Innovative Obesity Care

Updated Category News Views 117

Fractyl Health and Bariendo Collaborate on Innovative Solutions Fractyl Health, Inc. (NASDAQ: GUTS), a company dedicated to pioneering new approaches to obesity treatment, has entered into an exciting partnership with Bariendo Inc., an all-in-one obesity care platform. This collaboration is a proactive step aimed at exploring the future of Fractyl’s investigational...

Continue Reading
Medpace's Challenges Emerge as Stock Downgraded by Baird

Updated Category News Views 378

Insights into Medpace's Recent Stock Downgrade Recently, Baird has reassessed its perspective on Medpace Holdings Inc. (NASDAQ: MEDP) by downgrading the stock rating from Outperform to Neutral. Alongside this change, they reduced the price target significantly from $413 to $349. This shift reflects the evolving challenges Medpace faces, despite their historical success in...

Continue Reading
Travere Therapeutics Reaches New Heights: Stock Performance Insights

Updated Category News Views 80

Travere Therapeutics Stock Performance Shines In a remarkable display of market confidence, Travere Therapeutics Inc. (TVTX) stock has reached a significant milestone by hitting a 52-week high of $18.63. This achievement reflects an impressive 171.22% increase in stock price over the past year, showcasing a period of substantial growth for the company. Investors have...

Continue Reading
Cizzle Brands Launches on Cboe Canada with Exciting Prospects

Updated Category News Views 89

Cizzle Brands Debuts on Cboe Canada Cboe Canada has recently welcomed Cizzle Brands Corporation as it makes its public markets debut, introducing an exciting chapter for the Canadian-based company specializing in sports nutrition. This debut under the trading symbol CZZL signifies a significant milestone as Cizzle seeks to expand its reach in the competitive market of...

Continue Reading
Concerns Raised About Waymo's Arrival in Atlanta Amid Safety Risks

Updated Category News Views 394

Concerns Over Self-Driving Cars in Atlanta As autonomous vehicles continue to grab headlines, Attorney Amy Witherite, a renowned traffic safety expert, has voiced significant concerns regarding their impending arrival in Atlanta. Recently, numerous incidents across various cities have illuminated the potential hazards associated with these self-driving cars. From...

Continue Reading